Indirect Purchasers Reach $2.2M Settlement With Chinese Vitamin C Makers

Indirect Purchasers Reach $2.2M Settlement With Chinese Vitamin C Makers

NEW YORK - Indirect purchasers on Dec. 13 moved for preliminary approval of a $2.2 million settlement with Weisheng Pharmaceutical Co. Ltd. and CSPC Pharmaceutical Group Ltd. - two Chinese manufacturers of vitamin C - on the indirect purchasers' allegations that the defendants conspired to unlawfully fix prices of vitamin C to be exported to the United States and committed other unlawful practices designed to inflate the prices of vitamin C sold to the purchasers in the United States (In re Vitamin C Antitrust Litigation $(All Indirect Purchaser Actions$), Nos. 06-MD-1738, 06-988, 06-987, 06-149, E.D.N.Y.).

Find full version on lexis Advance®
Access this news story on lexis.com®